GTHX > The claim is Trilaciclib protects HSPC's which eliminates chemo related neutropenia and lymphopenia resulting in fewer transfusions, dose delays & reductions etc.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.